Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Discovery of MK-8282 as a Potent G-Protein-Coupled Receptor 119 Agonist for the Treatment of Type 2 Diabetes.
Neelamkavil SF, Stamford AW, Kowalski T, Biswas D, Boyle C, Chackalamannil S, Xia Y, Jayne C, Neustadt B, Hao J, Liu H, Dai X, Baker H, Hawes B, O'Neill K, Tang H, Greenlee WJ. Neelamkavil SF, et al. Among authors: baker h. ACS Med Chem Lett. 2018 Apr 10;9(5):457-461. doi: 10.1021/acsmedchemlett.8b00073. eCollection 2018 May 10. ACS Med Chem Lett. 2018. PMID: 29795759 Free PMC article.
Azabicyclic sulfonamides as potent 11beta-HSD1 inhibitors.
Shah U, Boyle CD, Chackalamannil S, Baker H, Kowalski T, Lee J, Terracina G, Zhang L. Shah U, et al. Among authors: baker h. Bioorg Med Chem Lett. 2010 Mar 1;20(5):1551-4. doi: 10.1016/j.bmcl.2010.01.082. Epub 2010 Jan 25. Bioorg Med Chem Lett. 2010. PMID: 20149650
Research in Brief.
Baker H. Baker H. Lancet Gastroenterol Hepatol. 2025 Feb;10(2):112. doi: 10.1016/S2468-1253(24)00440-0. Lancet Gastroenterol Hepatol. 2025. PMID: 39805282 No abstract available.
Research in Brief.
Baker H. Baker H. Lancet Gastroenterol Hepatol. 2025 Jan;10(1):23. doi: 10.1016/S2468-1253(24)00403-5. Lancet Gastroenterol Hepatol. 2025. PMID: 39674221 No abstract available.
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, Felton TW, Ghuman BK, Gordon AC, Hellyer TP, Lone NI, Manazar U, Richards G, McCullagh IJ, McMullan R, McNamee JJ, McNeil HC, Mouncey PR, Naisbitt MJ, Parker RJ, Poole RL, Rostron AJ, Singer M, Stevenson MD, Walsh TS, Welters ID, Whitehouse T, Whiteley S, Wilson P, Young KK, Perkins GD, Lall R; ADAPT-Sepsis Collaborators. Dark P, et al. JAMA. 2024 Dec 9. doi: 10.1001/jama.2024.26458. Online ahead of print. JAMA. 2024. PMID: 39652885
An international survey on the knowledge, attitudes and clinical patterns of use of medical cannabis for cancer care: The TASMAN study.
Trapani D, Nidhamalddin SJ, Gandini S, Filetti M, Altuna SC, Carnevale Schianca A, Petrillo A, Murthy SM, Girardi F, Bezuidenhout JB, El Bairi K, Lombardi P, Khan SZ, Lengyel CG, Seeber A, Hussain S, Seid FU, Elfaham E, Odhiambo AO, Coskun Y, Baker HS, Chowdhury AR, Genazzani A, Daniele G, Porzio G, Curigliano G, Giusti R. Trapani D, et al. Among authors: baker hs. Eur J Cancer. 2025 Jan 17;215:115158. doi: 10.1016/j.ejca.2024.115158. Epub 2024 Nov 30. Eur J Cancer. 2025. PMID: 39647216
2,119 results